通过肠系膜上动脉植入导管系统用于重复肝动脉灌注化疗。
Implantation of a port-catheter system through the superior mesenteric artery for repeated hepatic arterial infusion chemotherapy.
作者信息
Yamagami Takuji, Kato Takeharu, Hirota Tatsuya, Yoshimatsu Rika, Matsumoto Tomohiro, Nishimura Tsunehiko
机构信息
Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-chyo, Kawaramachi-Hirokoji, Kamigyo, Kyoto, 602-8566, Japan.
出版信息
J Vasc Interv Radiol. 2007 Dec;18(12):1595-600. doi: 10.1016/j.jvir.2007.10.002.
Between March 1999 and March 2006, 292 patients at the authors' institution required placement of a percutaneously implantable port-catheter system through which repeated hepatic arterial infusion chemotherapy would be administered. In 10 patients, the port-catheter system was implanted through the superior mesenteric artery. In these patients, implantation through the superior mesenteric artery instead of the celiac artery was necessary because all hepatic arteries arose from the superior mesenteric artery or because the blood supply to almost all tumors was from a hepatic artery arising from the superior mesenteric artery. Implantation of the port-catheter system was successful without complications in these 10 patients.
1999年3月至2006年3月期间，作者所在机构的292例患者需要植入经皮植入式端口导管系统，以便通过该系统反复进行肝动脉灌注化疗。在10例患者中，端口导管系统是通过肠系膜上动脉植入的。在这些患者中，之所以有必要通过肠系膜上动脉而非腹腔动脉进行植入，是因为所有肝动脉均发自肠系膜上动脉，或者几乎所有肿瘤的血供都来自发自肠系膜上动脉的肝动脉。这10例患者的端口导管系统植入成功，且无并发症发生。
Zotero 插件